文献速递免疫规划慢病防控与筛查

五个流感季节中老年人流感疫苗效果与青壮年比较

Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
PubMed 文献 · Vaccine · 2018-01-01

该研究汇总美国流感疫苗效果网络2011-12至2015-16五个流感季节≥18岁成人数据,纳入20,022人,其中4,785人(24%)流感检测阳性。结果显示≥65岁与18-49岁成人相比,各亚型疫苗效果均无显著降低,年龄与接种无显著交互作用;A(H3N2)在所有年龄组保护水平均较低。

要点

  • ≥65岁成人各亚型疫苗效果较18-49岁成人无显著降低
  • A(H3N2)疫苗效果:≥65岁14%,18-49岁21%
  • A(H1N1)pdm09与B型疫苗效果在两个年龄组相近

核心结论

  • 五个流感季节中,流感疫苗接种对老年人与年轻成人提供了相似水平的保护,所有年龄组对甲型H3N2流感的保护水平均较低。

研究设计与样本

  • 研究为对美国流感疫苗效果网络五个流感季节(2011-12至2015-16)数据的汇总分析,纳入系统入组的≥18岁成人20,022例,其中4,785例(24%)流感检测阳性。
  • 研究对象为因医学就诊的急性呼吸道疾病门诊患者(入组前7天内起病的咳嗽),采用逆转录聚合酶链反应检测流感。
  • 按流感型和亚型,以交互项检验年龄与接种的统计学显著性,比较65-74岁、≥75岁及≥65岁组与18-49岁组的疫苗效果差异及疫苗失败,并按既往季节接种状态分层。

主要发现

  • ≥65岁成人疫苗效果较18-49岁成人对任何亚型均无显著降低,年龄与接种无显著交互作用。
  • 甲型H3N2疫苗效果:≥65岁为14%(95%CI -14%至36%),18-49岁为21%(95%CI 9%至32%)。
  • 甲型H1N1pdm09疫苗效果:≥65岁为49%(95%CI 22%至66%),18-49岁为48%(95%CI 41%至54%)。
  • 乙型流感疫苗效果:≥65岁为62%(95%CI 44%至74%),18-49岁为55%(95%CI 45%至63%)。
  • 按既往接种状态分层后,各层年龄与接种均无显著交互作用。

关键数值与推荐

  • 甲型H3N2疫苗效果:≥65岁14%(95%CI -14%至36%)vs 18-49岁21%(95%CI 9%至32%)。
  • 甲型H1N1pdm09疫苗效果:≥65岁49%(95%CI 22%至66%)vs 18-49岁48%(95%CI 41%至54%)。
  • 乙型流感疫苗效果:≥65岁62%(95%CI 44%至74%)vs 18-49岁55%(95%CI 45%至63%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There have been inconsistent reports of decreased vaccine effectiveness (VE) against influenza viruses among older adults (aged ≥ 65 years) compared with younger adults in the United States. A direct comparison of VE over multiple seasons is needed to assess the consistency of these observations. METHODS: We performed a pooled analysis of VE over 5 seasons among adults aged ≥ 18 years who were systematically enrolled in the U.S. Flu VE Network. Outpatients with medically-attended acute respiratory illness (cough with illness onset ≤ 7 days prior to enrollment) were tested for influenza by reverse transcription polymerase chain reaction. We compared differences in VE and vaccine failures among older adult age group (65-74, ≥75, and ≥ 65 years) to adults aged 18-49 years by influenza type and subtype using interaction terms to test for statistical significance and stratified by prior season vaccination status. RESULTS: Analysis included 20,022 adults aged ≥ 18 years enrolled during the 2011-12 through 2015-16 influenza seasons; 4,785 (24%) tested positive for influenza. VE among patients aged ≥ 65 years was not significantly lower than VE among patients aged 18-49 years against any subtype with no significant interaction of age and vaccination. VE against A(H3N2) viruses was 14% (95% confidence interval [CI] -14% to 36%) for adults ≥ 65 years and 21% (CI 9-32%) for adults 18-49 years. VE against A(H1N1)pdm09 was 49% (95% CI 22-66%) for adults ≥ 65 years and 48% (95% CI 41-54%) for adults 18-49 years and against B viruses was 62% (95% CI 44-74%) for adults ≥ 65 years and 55% (95% CI 45-63%) for adults 18-49 years. There was no significant interaction of age and vaccination for separate strata of prior vaccination status. CONCLUSIONS: Over 5 seasons, influenza vaccination provided similar levels of protection among older and younger adults, with lower levels of protection against influenza A(H3N2) in all ages.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Russell K, Chung JR, Monto AS, et al. Influenza vaccine effectiveness in older adults compared with younger adults over five seasons. Vaccine. 2018. PMID: 29402578. doi:10.1016/j.vaccine.2018.01.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。